Влияние терапии бисопрололом на перфузию головного мозга у больных с метаболическим синдромом
Аннотация
Об авторах
В. Б. МычкаРоссия
В. Б. Сергиенко
Россия
В. В. Горностаев
Россия
И. М. Двоскина
Россия
И. Е. Чазова
Россия
Список литературы
1. Bertel O, Marx B, Conen D. Effects of antihypertensive treatment on cerebral perfusion. Am J Med 1987; 82-29.
2. Meyer J.S, Rogers R.L, Mortel R.F. Prospective analysis of long - term control of mild hypertension in cerebral blood flow. Stroke 1985; 16 (6): 985-90.
3. Hares P, James I.M, Griffith D. Effect of acebutolol on cerebral circulation of a man. Br J Clin Pharmacol 1977; 4: 373-5.
4. Fuijshima M, Ibayashi S, Fugii K et al. Effects of long - term antihypertensive treatment on cerebral thalamic and cerebral blood flow in spontaneously hypertensive rats SHR. Stroke 1986; 17-5.
5. Fogari R, Zoppi A, Corradi L et al. b - blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia. J Cardiovasc Pharmacol 1999; 534-9.
6. Vulpis V, Antonacci A, Prandi P et al. The effects of bisoprolol and atenolol on glucose metabolism in hypertensive patients with non - insulin dependent diabetes mellitus. Minerva Med 1991; 82: 189-93.
7. Верещагин Н.В.,Борисенко В.В., Власенко В.В. Мозговое кровообращение. Современные методы исследования в клинической неврологии.
8. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. Br Med J 1998; 317: 713-9.
9. Frithz G. Influense on plasma - insulin and blood - glucose by treatment with bisoprolol in hypertensive, non - diabetic patients. J Clin Basic Cardiol 2001; 4: 229-30.
10. Fogari R et al. b - blocker effects on plasma lipids in antihypertensive therapy: importance of the duration of treatment and the lipid status before treatment. J Cardivasc Pharmacol 1990; 16 (suppl 5): S76.
11. Chang P.C, van Veen S, Vermeij P, van Brummelen P. Double - blind compason of the b1-selectivity of single doses of bisoprolol and atenolol. J Cardiovasc Pharmacol 1986; 8 (Suppl 11): S58-60.
12. Asmar R.G, Kerihuel J.C, Girerd X.J, Safar M.E. Effect of bisoprolol on blood pressure and arterial hemodinamyc hypertension. Am J Cardiol 1991; 68: 61-4.
13. Frithz G, Weiner L. Effects of bisoprolol on blood pressure, serum lipids and HDL-cholesterol in essential hypertension. Eur J Clin Pharmacol 1987; 32: 77-80.
14. Haneda T, Ido A, Fijikane T et al. Effect of bisoprolol, a b1-selective b - blocer, on lipid and glucose metabolism and quality of life in elderly patients with essential hypertension. Jpn J Geriat 1998; 35: 33-8.
15. Janka H.U, Ziegler A.G, Disselhoff G, Mehnert H. Influece of bisiprolol on blood glucose, glucosuria and haemoglobin A1, in non - insulin - dependent diabetics. J Cardivasc Pharmacol 1986; 8 (suppl 11): s 96-9.
16. Dominguez L.J, Barbagallo M, Jacober S.J et al. Bisoprolol and captopril effects on insulin receptor tyrosine kinase activity in essential hypertension. Am J Hypertens 1997; 10: 1349-55.
Рецензия
Для цитирования:
Мычка В.Б., Сергиенко В.Б., Горностаев В.В., Двоскина И.М., Чазова И.Е. Влияние терапии бисопрололом на перфузию головного мозга у больных с метаболическим синдромом. Системные гипертензии. 2006;(1):15-18.
Послать статью по эл. почте 